Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial
- PMID: 24779384
- PMCID: PMC4022327
- DOI: 10.1186/1741-7015-12-69
Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial
Abstract
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abstracts. However, no specific recommendation is related to the reporting of conflicts of interest (CoI). The objective was to compare physicians' confidence in the conclusions of abstracts of randomized controlled trials of pharmaceutical treatment indexed in PubMed.
Methods: We planned a three-arm parallel-group randomized trial. French general practitioners (GPs) were invited to participate and were blinded to the study's aim. We used a representative sample of 75 abstracts of pharmaceutical industry-funded randomized controlled trials published in 2010 and indexed in PubMed. Each abstract was standardized and reported in three formats: 1) no mention of the funding source or CoI; 2) reporting the funding source only; and 3) reporting the funding source and CoI. GPs were randomized according to a computerized randomization on a secure Internet system at a 1:1:1 ratio to assess one abstract among the three formats. The primary outcome was GPs' confidence in the abstract conclusions (0, not at all, to 10, completely confident). The study was planned to detect a large difference with an effect size of 0.5.
Results: Between October 2012 and June 2013, among 605 GPs contacted, 354 were randomized, 118 for each type of abstract. The mean difference (95% confidence interval) in GPs' confidence in abstract findings was 0.2 (-0.6; 1.0) (P = 0.84) for abstracts reporting the funding source only versus no funding source or CoI; -0.4 (-1.3; 0.4) (P = 0.39) for abstracts reporting the funding source and CoI versus no funding source and CoI; and -0.6 (-1.5; 0.2) (P = 0.15) for abstracts reporting the funding source and CoI versus the funding source only.
Conclusions: We found no evidence of a large impact of trial report abstracts mentioning funding sources or CoI on GPs' confidence in the conclusions of the abstracts.
Trial registration: ClinicalTrials.gov identifier: NCT01679873.
Figures
Similar articles
-
Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.Trials. 2017 Jul 26;18(1):354. doi: 10.1186/s13063-017-2108-z. Trials. 2017. PMID: 28747226 Free PMC article.
-
Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.World J Surg. 2014 Oct;38(10):2487-93. doi: 10.1007/s00268-014-2580-5. World J Surg. 2014. PMID: 24824646
-
Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials.Breast. 2017 Jun;33:29-33. doi: 10.1016/j.breast.2017.02.016. Epub 2017 Mar 6. Breast. 2017. PMID: 28273553
-
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.JAMA. 2011 Mar 9;305(10):1008-17. doi: 10.1001/jama.2011.257. JAMA. 2011. PMID: 21386079 Review.
-
Time trends in the reporting of conflicts of interest, funding and affiliation with industry in intensive care research: a systematic review.Intensive Care Med. 2018 Oct;44(10):1669-1678. doi: 10.1007/s00134-018-5350-2. Epub 2018 Aug 23. Intensive Care Med. 2018. PMID: 30141174
Cited by
-
Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.Ann Oncol. 2019 Jan 1;30(1):96-102. doi: 10.1093/annonc/mdy462. Ann Oncol. 2019. PMID: 30335127 Free PMC article. Clinical Trial.
-
Effect of different financial competing interest statements on readers' perceptions of clinical educational articles: a randomised controlled trial.BMJ Open. 2019 Feb 19;9(2):e025029. doi: 10.1136/bmjopen-2018-025029. BMJ Open. 2019. PMID: 30782923 Free PMC article. Clinical Trial.
-
Research on policy mechanisms to address funding bias and conflicts of interest in biomedical research: a scoping review.Res Integr Peer Rev. 2025 May 14;10(1):6. doi: 10.1186/s41073-025-00164-0. Res Integr Peer Rev. 2025. PMID: 40361202 Free PMC article.
-
Publication and non-publication of drug trial results: a 10-year cohort of trials in Norwegian general practice.BMJ Open. 2016 Apr 11;6(4):e010535. doi: 10.1136/bmjopen-2015-010535. BMJ Open. 2016. PMID: 27067893 Free PMC article. Review.
-
Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.J Health Commun. 2016 Nov;21(11):1198-1207. doi: 10.1080/10810730.2016.1237594. Epub 2016 Nov 2. J Health Commun. 2016. PMID: 27805473 Free PMC article. Clinical Trial.
References
-
- Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012;12:MR000033. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical